Search Results
Dec 03, 2025, 12:00 ET ImpriMed to Present Ex Vivo Drug Sensitivity Data in Acute Myeloid Leukemia in Oral Presentation at American Society of Hematology Annual Meeting
survival"Poster Presentation Details:Session: 803. Emerging Tools, Techniques, and Artificial Intelligence in Hematology: Poster IIIDate/Time: December 8, 2025, 6:00 PM - 8:00 PMPublication Number: 6137Title: "Quantitative ex vivo synergy profiling uncovers
More news about: ImpriMed
Dec 03, 2025, 12:00 ET Unlikely Collaborators Sponsors Free Speaker Event in Santa Monica: "Are You a Spectator to Reality? Or Are You Its Creator?" with Lisa Feldman Barrett, PhD
artists, and collaborators for conversations that challenge perspectives and deepen connections. Past speakers have included illusionist Harris III, psychologist Scott Barry Kaufman, PhD, nutrition therapist Kim Shapira, MS, RD, mythologist John Bucher, Harvard Business School
More news about: Unlikely Collaborators
Dec 03, 2025, 11:11 ET Straightforward Guide to Funding Featured in LibraryBub Selection for December
book, The Funding Framework, author Vijay Rajendran sets out clearly the steps involved in securing startup funding." Experienced CEO Carl Grant III admires the book's "clear, structured approach" which "makes navigating the fundraising process feel less intimidating". He can see how the book's real-world
More news about: LibraryBub
Dec 03, 2025, 10:55 ET PRGO INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Perrigo Company plc Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
to make substantial capital and operational expenditures above Perrigo's outwardly stated cost estimates to remediate the infant formula business; (iii) there were significant manufacturing deficiencies in the facility for Perrigo's infant formula business; and (iv) as a result of the foregoing, Perrigo's
More news about: Robbins Geller Rudman & Dowd LLP
Dec 03, 2025, 10:47 ET Davie Defense Closes Gulf Copper Acquisition, Confirming U.S. Shipbuilding Expansion
center, backed by its experienced management team and workforce, who will remain in place. Its work, including the recently expanded scope on the Flight III Arleigh Burke–class destroyer units, underscores its capability to execute complex, high-precision defense projects in Texas. Kai Skvarla, CEO of
More news about: Davie Defense
Dec 03, 2025, 09:55 ET La Iniciativa de Mercados Sostenibles organiza una reunión de movilización de capital privado en Londres
organiza una histórica reunión de movilización de capital privado en Londres, con una sesión de informes a la que asistió Su Majestad el Rey Carlos IIILONDRES, 3 de diciembre de 2025 /PRNewswire/ -- Ayer, la Iniciativa
More news about: Sustainable Markets Initiative
Dec 03, 2025, 09:52 ET サステナブル・マーケッツ・イニシアティブ、ロンドンで画期的な民間資本動員会議を開催 Charles III世国王出席の報告セッションも実施
View original content:https://www.prnewswire.com/jp/news-releases/-charles-iii-302631870.htmlSOURCE Sustainable Markets Initiative
More news about: Sustainable Markets Initiative
Dec 03, 2025, 09:30 ET Global X: Investing Outlook Complicated by Contradictions in U.S. Economy and Evolving Geopolitical Order
14, 2025, using the S&P 500 as a proxy for large caps.[ii] Source: Global X ETFs, as of September 30, 2025.[iii] Source: Mirae Asset, as of September 30, 2025.
More news about: Global X Management Company LLC
Dec 03, 2025, 09:03 ET Granata Bio Reports Strong Enrollment Momentum in Pivotal Phase III GRACE Study of Investigational Gonadotropin for Assisted Reproductive Technology
Granata Bio Corporation, a biotechnology company advancing innovative reproductive health solutions, announced strong momentum in its pivotal Phase III clinical study, with multiple subjects already screened to evaluate the safety and efficacy of its investigational gonadotropin product for use in assisted
More news about: Granata Bio
Dec 03, 2025, 09:00 ET Griffith Foods Predicts 2026 Food and Flavor Trends
www.griffithfoods.com i FMCG Gurus February 2025 MPP919, MPP964, MPP740ii FMCG Gurus March 2025 FCT945-FCT027iii Kentley Insight – Global Market Size & Growth Report Food Trucks & Street Vendors July 2025iv Source: Source: Ai Palette
More news about: Griffith Foods
Dec 03, 2025, 08:59 ET Vanguard Launches Target Retirement Lifetime Income Trusts
will fluctuate in value.ii Based on data in PLANSPONSOR's 2025 DC Recordkeeping Survey published June 25, 2025.iii As of December 31, 2024, TIAA paid out $5.9B in total annuity income. This figure represents all annuity income, including guaranteed and additional
More news about: Vanguard
Dec 03, 2025, 08:16 ET Natural Grocers® Invites Grand Junction, CO Community to Celebrate Grand Reopening on December 17, 2025
Grocers' Grand Junction, CO location. No rain checks. Limit one per customer, 18 years or older. Valid 12/17/25 only. Void where prohibited by law.[iii] Quantity limited to next 250 shoppers at Natural Grocers' Grand Junction, CO location. No rain checks. Limit one per customer, 18 years or older.
More news about: Natural Grocers by Vitamin Cottage, Inc.
Dec 03, 2025, 08:10 ET Emerald Clinical Appoints Luke Gill as Vice President, Global Head of Oncology, Medical & Scientific Affairs
management across the biotech and CRO sectors. He has led global oncology programs from first-in-human and translational research through pivotal Phase III trials and regulatory submissions, driving operational excellence and scientific rigor throughout the process.Before joining Emerald, Luke held
More news about: Emerald Clinical Trials
Dec 03, 2025, 08:10 ET Emerald Clinical Appoints Luke Gill as Vice President, Global Head of Oncology, Medical & Scientific Affairs
management across the biotech and CRO sectors. He has led global oncology programs from first-in-human and translational research through pivotal Phase III trials and regulatory submissions, driving operational excellence and scientific rigor throughout the process.Before joining Emerald, Luke held
More news about: Emerald Clinical Trials
Dec 03, 2025, 08:01 ET REI Systems Awarded Follow-On SBIR Phase III Contract by the National Science Foundation to Advance and Expand Its Modernized Proposal Evaluation System (PES)
REI Systems, a leading provider of innovative government technology solutions, announced today that it has been awarded a follow-on SBIR Phase III contract from the National Science Foundation (NSF) to operate, enhance, and expand NSF's modernized Proposal Evaluation System (PES). This award builds
More news about: REI Systems
Dec 03, 2025, 07:00 ET Shoulder Innovations Announces Strategic Partnership with INS to Introduce a Robotic Platform for Shoulder Arthroplasty
forward-looking statement, including (i) the Company's history of significant net losses; (ii) failure to manage the growth of the Company's business; (iii) the Company's inability to compete successfully against its existing or potential competitors; (iv) failure to develop, retain, or expand an effective
More news about: Shoulder Innovations
Dec 03, 2025, 06:00 ET NEVADA KING COMPLETES PURCHASE OF SILVER PARK PATENTED MINING CLAIMS
Atlanta Resource Zone.John Sclodnick, CEO of Nevada King commented: "Not only has the Silver Park target area become a key focus of our Phase III regional exploration program with gold and silver mineralization now confirmed over a 450m by 300m footprint with clear expansion potential, but the
More news about: Nevada King Gold Corp.
Dec 03, 2025, 05:04 ET Waterdrop Inc. Announces Third Quarter 2025 Unaudited Financial Results
primarily driven by (i) an increase of RMB66.7 million in costs of referral and service fees, (ii) an increase of RMB32.4 million in personnel costs, and (iii) an increase of RMB16.9 million in the costs for the crowdfunding consultants team. On a quarter-over-quarter basis, operating costs increased by 14.1%
More news about: Waterdrop Inc.
Dec 03, 2025, 01:11 ET Westlake University Establishes Department of Astronomy
universe.The department will draw on best practices from leading universities worldwide, integrating training in theory, observation, and computation. Phase III of the Yungu Campus includes a small observatory equipped with an 80-cm telescope, expected to be operational and open for educational use after the
More news about: Westlake University
Dec 03, 2025, 00:40 ET Cango Inc. Terbitkan Laporan Keuangan Periode Triwulan III-2025 yang Tidak Diaudit
Kinerja Keuangan dan Operasional Periode Triwulan III-2025Pendapatan total mencapai US$224,6 juta pada Triwulan III-2025, meningkat 60,6% dari Triwulan II-2025. Pendapatan dari bisnis penambangan bitcoin pada Triwulan III-2025 tercatat US$220,9 juta.Pendapatan operasional
More news about: Cango Inc.
Dec 02, 2025, 22:54 ET Initiative für nachhaltige Märkte veranstaltet bahnbrechende Konferenz zur Mobilisierung von Privatkapital in London, mit einer Berichtssitzung in Anwesenheit Seiner Majestät König Karl III.
entscheidende Wachstumsmotor des kommenden Jahrzehnts.Über die Initiative für nachhaltige Märkte Das von Seiner Majestät König Karl III. gegründete SMI ist die weltweit führende von CEOs geführte Koalition, die den Übergang zu einer nachhaltigen Zukunft beschleunigt.
More news about: Sustainable Markets Initiative
Dec 02, 2025, 22:50 ET La Sustainable Markets Initiative organise à Londres une réunion historique sur la mobilisation des capitaux privés, à laquelle Sa Majesté le Roi Charles III a assisté.
croissance déterminant de la décennie à venir.À propos de l'initiative pour des marchés durables Fondée par Sa Majesté le Roi Charles III, la SMI est la principale coalition mondiale dirigée par des chefs d'entreprise qui accélère la transition vers un avenir durable.
More news about: Sustainable Markets Initiative
Dec 02, 2025, 18:16 ET Accord Healthcare annonce le lancement de son deuxième biosimilaire du denosumab dans le domaine de la santé osseuse
JUBEREQL'autorisation d'OSVYRTI et JUBEREQ a été accordée sur la base des résultats de deux essais : un essai de phase I et un essai de phase III ayant tous deux atteint leurs objectifs principaux. L'essai de phase I était une étude pharmacocinétique randomisée, en double aveugle, à trois bras,
More news about: Accord Healthcare
Dec 02, 2025, 18:11 ET Accord Healthcare kündigt Einführung von Denosumab∇ an - zweites Biosimilar im Bereich Knochengesundheit
OSVYRTI und JUBEREQDie Zulassung von OSVYRTI und JUBEREQ basierte auf den Ergebnissen von zwei Studien: eine Phase-I-Studie und eine Phase-III-Studie, die ihre primären Endpunkte erreicht haben. Die Phase-I-Studie war eine randomisierte, doppelblinde, dreiarmige pharmakokinetische (PK) Studie
More news about: Accord Healthcare
Dec 02, 2025, 18:00 ET Accord Healthcare anuncia el lanzamiento de Denosumab∇, el segundo biosimilar para la salud ósea
de OSVYRTI y JUBEREQLa aprobación de OSVYRTI y JUBEREQ se basó en los resultados de dos ensayos: un ensayo de fase I y un ensayo de fase III que cumplieron sus criterios de valoración principales. El ensayo de fase I fue un estudio farmacocinético (FC) aleatorizado, doble ciego, de tres brazos,
More news about: Accord Healthcare